Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIOD-123 vs Insulin Lispro in Type 1 Diabetes
NCT01686620Phase 2Completed
- Sponsor
- Biodel Inc.
- Start
- Aug 2012
- Primary completion
- Jun 2013
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BIOD-123 in type 1 diabetes mellitus (T1D), sponsored by Biodel Inc.. Started Aug 2012; status: completed.
02
Drugs
BIOD-123
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01686620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01686620.